In DepthBiomedical Research

Scripps hooks prominent pair to lead it to health

See allHide authors and affiliations

Science  25 Sep 2015:
Vol. 349, Issue 6255, pp. 1435
DOI: 10.1126/science.349.6255.1435

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The Scripps Research Institute has named two eminent scientists to lead one of the world's largest private biomedical research institutions. Scripps chemist Peter Schultz will serve as CEO, while Steve Kay, formerly a dean at the University of Southern California (USC), will serve as president. The announcement ends a contentious period between Scripps leadership and its faculty, who revolted a year ago when Scripps leaders attempted to merge the institute with USC. Schultz and Kay say they intend to marry the institute's historic strength in basic research with a new emphasis on translational research that aims to turn discoveries into medicines. If they succeed, the duo say, that should stabilize the institute's long-term finances.